Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: A Study to Extend Efficacy and Safety of SHR-1819 Injection in Adult Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 study of SHR-1819 injection in adults with moderate to severe atopic dermatitis has completed, with a status update provided.
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)
An update on a clinical trial evaluating adverse events and changes in disease state for oral upadacitinib in adolescents aged 12 to <18 wit…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: A Study to Assess Change in Disease Activity in Adolescents and Adults With Moderate to Severe Prurigo-type Atopic Dermatitis in Japan Who Are Treated With Oral Upadacitinib
A completed clinical trial evaluating change in disease activity in adolescents and adults with moderate-to-severe prurigo-type atopic derma…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis [Phase 2]
Phase 2 efficacy and safety trial of RPT193 in adults with atopic dermatitis was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists
A completed clinical trial evaluating Legit.Health Plus Support as a diagnostic aid for generalized pustular psoriasis and other skin condit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic Dermatitis [Phase 3]
Phase 3 trial assessing safety and efficacy of upadacitinib in combination with topical corticosteroids for children aged 2 to under 12 with…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis [Phase 2]
A Phase 2 trial evaluating different doses of LEO 138559 in adults with moderate-to-severe atopic dermatitis has completed enrollment and re…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis
A completed clinical trial evaluating adverse events and changes in disease symptoms in Korean participants with rheumatoid arthritis, atopi…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Evaluate the Safety, Tolerability of BAT6026 [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and tolerability of BAT6026 for atopic dermatitis; the study is currently active but not recr…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: PGE2/IL-22 Pathway in Various Forms of Eczema
NHS Lothian reports the completion of a clinical trial investigating the PGE2/IL-22 pathway in eczema. The study pertains to atopic dermatit…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: A Phase III Study of GS101 Injection to Dupixent® [Phase 3]
A Phase 3 clinical trial evaluating GS101 Injection in combination with Dupixent for atopic dermatitis is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: TRacking Atopic Dermatitis Infants and Their Microbiome (TRAM)
A completed clinical trial (TRAM) that tracks the microbiome in infants with atopic dermatitis and pediatric acute lymphoblastic leukemia, s…
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD) [Phase 1]
Phase 1 study of KT-621 in adults with atopic dermatitis reported safety, pharmacokinetics, pharmacodynamics, and early clinical activity.
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Comparative Study of Crisaborole vs. Tacrolimus in Atopic Dermatitis [Phase 4]
A Phase 4 comparative study is evaluating Crisaborole versus Tacrolimus for atopic dermatitis. The trial status is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants [Phase 1]
A Phase 1 study evaluated the bioavailability of Rocatinlimab administered via autoinjector and vial in healthy participants. Sponsored by A…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) [Phase 3]
Phase 3 trial completion update for Rocatinlimab (AMG 451) in adolescent patients with moderate-to-severe Atopic Dermatitis.
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: A Study to Evaluate Microneedle-based Collection of Dermal Interstitial Skin Fluid in Healthy Participants and Atopic Dermatitis Participants
A clinical trial evaluating microneedle-based collection of dermal interstitial fluid in healthy volunteers and patients with atopic dermati…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic Dermatitis [Phase 3]
A Phase 3 clinical trial evaluating 611, a recombinant anti-IL-4 receptor alpha monoclonal antibody, in Chinese adults with moderate-to-seve…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis [Phase 3]
Pfizer completed a Phase 3 trial evaluating PF-04965842, with or without topical medications, for moderate to severe atopic dermatitis in pa…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of LNK01004 Ointment in Adults With Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of LNK01004 Ointment in adults with Atopic Dermatitis has completed. The study i…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Probiotic on Atopic Dermatitis in Infant [NA]
A completed clinical trial sponsored by Glac Biotech evaluated a probiotic for atopic dermatitis in infants.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participants [Phase 1]
Phase 1 study evaluating Rocatinlimab (AMG-451) in healthy Chinese participants has completed, with Atopic Dermatitis identified as the cond…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Comparison Between Topical N-acetyl Cysteine (NAC) in Cold Cream Versus Cold Cream in Mild and Moderate Atopic Dermatitis: Clinical and Bacteriological Evaluation. A Randomized Control Trial. [NA]
A completed randomized controlled trial evaluated topical N-acetylcysteine in cold cream versus cold cream alone for mild to moderate atopic…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial [Phase 4]
A Phase 4 open-label trial evaluated dupilumab in adolescent and adult participants with moderate-to-severe atopic dermatitis in skin of col…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating the efficacy and safety of SCD-044 in moderate-to-severe atopic dermatitis has completed, with results posted.